| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/15/2010 | WO2009142810A3 Methods for treating or preventing colorectal cancer |
| 07/15/2010 | WO2009117558A3 Destruction of microbial products by enzymatic digestion |
| 07/15/2010 | WO2009111278A3 Raf inhibitor compounds and methods of use thereof |
| 07/15/2010 | WO2009103821A3 Regulators of pb1-f2 activity for treating virus infections |
| 07/15/2010 | WO2009098051A8 Aryl sulfonamides as effective analgesics |
| 07/15/2010 | WO2009076141A8 Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 07/15/2010 | WO2009074247A8 Novel 2-aryl-thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament |
| 07/15/2010 | WO2009033282A8 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects |
| 07/15/2010 | WO2008132723A3 Therapeutic delivery of inhibitory nucleic acid molecules to the respiratory system |
| 07/15/2010 | US20100179309 MODIFIED iRNA AGENTS |
| 07/15/2010 | US20100179227 Production method of hop preparation, hop preparation, anti-inflammatory agent, food product and beverage, and oral product |
| 07/15/2010 | US20100179226 Topical Dosage Form Comprising Tri-Substituted Glycerol Compounds |
| 07/15/2010 | US20100179225 POI Prevention |
| 07/15/2010 | US20100179224 Acyclic Sulfamide Derivatives |
| 07/15/2010 | US20100179223 Compounds, Compositions, and Methods for the Treatment of Synucleinopathies |
| 07/15/2010 | US20100179221 Fluorine-substituted amphetamines and amphetamine derivatives and use thereof |
| 07/15/2010 | US20100179220 Method for the treatment of tinnitus |
| 07/15/2010 | US20100179219 Plane Tree Cream, Method for the Production Thereof and Use |
| 07/15/2010 | US20100179218 Oculoselective drugs and prodrugs |
| 07/15/2010 | US20100179217 Therapeutic compounds |
| 07/15/2010 | US20100179216 Amine compound and pharmaceutical use thereof |
| 07/15/2010 | US20100179215 Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders |
| 07/15/2010 | US20100179214 Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders |
| 07/15/2010 | US20100179213 Methods and Compositions Involving miRNAs In Cancer Stem Cells |
| 07/15/2010 | US20100179212 Pharmaceutical composition which improves in vivo gene transfer |
| 07/15/2010 | US20100179211 Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
| 07/15/2010 | US20100179210 Novel enantiomerically pure compounds for the treatment of proliferative disorders |
| 07/15/2010 | US20100179209 Pactimibe medicaments for preventing/treating a disease due to sebaceous gland dysfunction in humans or animals |
| 07/15/2010 | US20100179208 Use of HDAC Inhibitors for the Treatment of Bone Destruction |
| 07/15/2010 | US20100179207 Compounds |
| 07/15/2010 | US20100179203 Novel pyrazole derivatives useful as potassium channel modulators |
| 07/15/2010 | US20100179202 Orally disintegrating composition of zolmitriptan |
| 07/15/2010 | US20100179201 Novel thiazole-based compound and inhibitor of t-type calcium channel containing the same |
| 07/15/2010 | US20100179200 2-oxothiazolidine 4-carboxylic acid compounds for promoting desquamation of the skin |
| 07/15/2010 | US20100179199 Ethanamine Compounds and Methods of Using the Same 545 |
| 07/15/2010 | US20100179193 AMPA Receptor Antagonists and Zonisamide for Neuropathic Pain |
| 07/15/2010 | US20100179192 Use of nitric oxide releasing compounds in the treatment of chronic pain |
| 07/15/2010 | US20100179191 Glucopyranosyl-substituted cyclopropylbenzene derivatives, pharmaceutical compositions containing such compounds, their use as sglt inhibitors and process for their manufacture |
| 07/15/2010 | US20100179190 Bicyclic pyrazolo protein kinase modulators |
| 07/15/2010 | US20100179189 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 07/15/2010 | US20100179188 Nitroxide radical as treatment for neurodegeneration |
| 07/15/2010 | US20100179187 Indolone compounds useful to treat cognitive impairment |
| 07/15/2010 | US20100179186 USE OF A NOVEL ALPHA-7 nAChR ANTAGONIST TO SUPPRESS PATHOGENIC SIGNAL TRANSDUCTION IN CANCER AND AIDS |
| 07/15/2010 | US20100179185 Novel Aminothienopyridinone Derivatives Processes for Preparing Them and Pharmaceutical Compositions Thereof |
| 07/15/2010 | US20100179184 Article of manufacture for prasugrel |
| 07/15/2010 | US20100179183 Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders |
| 07/15/2010 | US20100179182 Pharmaceutical formulation |
| 07/15/2010 | US20100179181 Pharmaceutical formulations of biodegradable biocompatible camptothecin-polymer conjugates |
| 07/15/2010 | US20100179180 Crystalline irinotecan hydrochloride and methods for its preparation |
| 07/15/2010 | US20100179179 Inhibitors of the mutant form of kit |
| 07/15/2010 | US20100179178 Pyrimidine derivatives as posh and posh-ap inhibitors |
| 07/15/2010 | US20100179177 Heterocyclic compounds and their uses |
| 07/15/2010 | US20100179176 V3 antagonists for the treatment or prevention of chronic pain |
| 07/15/2010 | US20100179175 Use of pkc inhibitors in ocular diseases |
| 07/15/2010 | US20100179174 Substituted azaquinazolines having an antiviral action |
| 07/15/2010 | US20100179173 Substituted fused pyrimidines as antagonists of gpr105 activity |
| 07/15/2010 | US20100179171 Pharmacological Treatment of Parkinson's Disease |
| 07/15/2010 | US20100179170 Heterogeneously configured multiparticulate gastrointestinal drug delivery system |
| 07/15/2010 | US20100179169 which is ketoconazole; gout flares |
| 07/15/2010 | US20100179168 Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists |
| 07/15/2010 | US20100179167 Methods of using substituted isoxazolo pyridinones as dissociated glucocorticoids |
| 07/15/2010 | US20100179166 Carboxamide heterocyclic cgrp receptor antagonists |
| 07/15/2010 | US20100179165 Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds |
| 07/15/2010 | US20100179164 2,4-pyrimidinediamine compounds for treatment of inflammatory disorders |
| 07/15/2010 | US20100179163 Nol3 is a predictor of patient outcome |
| 07/15/2010 | US20100179162 Crystal forms of 4-[6-methoxy-7(3-piperidin-1-yl-propoxy) quinazoline-4yl) piperazine-1-carboxylic acid (4-isopropoxyphenyl)-amide |
| 07/15/2010 | US20100179161 Pyrazoline derivatives for the treatment of turberculosis |
| 07/15/2010 | US20100179160 Organic compounds |
| 07/15/2010 | US20100179159 Method for the production of a medicament containing tadalafil |
| 07/15/2010 | US20100179158 Inhibitors of cyclic amp phosphodiesterases |
| 07/15/2010 | US20100179157 Therapeutic agent for cerebral infarction |
| 07/15/2010 | US20100179155 Activators and therapeutic applications thereof |
| 07/15/2010 | US20100179154 6-CYCLOAMINO-3-(PYRID-4-YL)IMIDAZO[1,2-b]PYRIDAZINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF |
| 07/15/2010 | US20100179153 Bicyclic S1P Receptor Modulators |
| 07/15/2010 | US20100179152 Novel use for PDE5 inhibitors |
| 07/15/2010 | US20100179151 Transdermal application of triazines for controlling infections with coccidia |
| 07/15/2010 | US20100179150 Antibacterial piperdine derivatives |
| 07/15/2010 | US20100179149 Aryl ether pyridazinone derivatives |
| 07/15/2010 | US20100179148 Pyridazinone derivatives |
| 07/15/2010 | US20100179147 Benzimidazole compounds and their use as anticancer agents |
| 07/15/2010 | US20100179146 Indolinone Compounds as Kinase Inhibitors |
| 07/15/2010 | US20100179145 Pharmaceutical combinations |
| 07/15/2010 | US20100179144 Quinazoline derivatives as p13 kinase inhibitors |
| 07/15/2010 | US20100179143 Naphthyridine, derivatives as p13 kinase inhibitors |
| 07/15/2010 | US20100179142 Cancer Combination Therapy Comprising AZD2171 and ZD1839 |
| 07/15/2010 | US20100179141 Novel jnk inhibitors |
| 07/15/2010 | US20100179140 Indenoisoquinolinone analogs and methods of use thereof |
| 07/15/2010 | US20100179139 Pyrrolopyridine compounds, process for their preparation, and their use as medicaments |
| 07/15/2010 | US20100179138 Isozazole Compounds As Inhibitors Of Heat Shock Proteins |
| 07/15/2010 | US20100179137 Pyridone compound |
| 07/15/2010 | US20100179136 N-amino tetrahydrothiazine derivatives, method of manufacture and use |
| 07/15/2010 | US20100179135 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives |
| 07/15/2010 | US20100179134 Pyrimidinediamine kinase inhibitors |
| 07/15/2010 | US20100179133 Compositions, articles and methods comrising tspo ligands for preventing or reducing tobacco-associated damage |
| 07/15/2010 | US20100179132 Carboline derivatives useful in the inhibition of angiogenesis |
| 07/15/2010 | US20100179131 Combination treatment for diabetes mellitus |
| 07/15/2010 | US20100179130 Use of piperine and derivatives thereof for the therapy of neurological conditions |
| 07/15/2010 | US20100179129 Compositions of an anticonvulsant and mirtazapine to prevent weight gain |
| 07/15/2010 | US20100179128 Xanthine derivatives as selective hm74a agonists |
| 07/15/2010 | US20100179127 Pyrimidine derivatives |